Trademark Attorney / Law Firm
Xavier L. Suarez – Trademark Portfolio
Xavier L. Suarez specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 9 of 14 total filings concentrated in this category. The practice also covers Class 3 (Cosmetics & Cleaning) along with 3 other Nice Classification classes. Filing activity spans from 2020 to 2025. Currently, 6 trademarks are registered and 4 are pending.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Xavier L. Suarez's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademark applications has Xavier L. Suarez filed?
Xavier L. Suarez has filed 14 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 6 registered, 4 pending, 4 abandoned.
What trademark classes does Xavier L. Suarez specialize in?
Xavier L. Suarez has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has Xavier L. Suarez been filing trademarks?
Xavier L. Suarez's trademark filing history with the USPTO spans from 2020 to 2025, covering 5 years of trademark practice. During this period, Xavier L. Suarez has handled 14 trademark applications.
What is Xavier L. Suarez's trademark registration success rate?
Xavier L. Suarez has a 60% trademark registration rate, with 6 out of 10 resolved applications resulting in successful registration. Currently, 4 applications are pending review.